These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma? Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E. Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019 [Abstract] [Full Text] [Related]
3. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Gu CS, Kuruvilla MS, Cline KJ, Julian JA, Evans WK, Levine MN. J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082 [Abstract] [Full Text] [Related]
10. Combined transbronchial needle aspiration and PET/CT for mediastinal staging of lung cancer. Börekçi S, Elbek O, Bayram N, Uysal N, Bakır K, Zincirkeser S, Sanlı M, Dikensoy O, Ekinci E. Tuberk Toraks; 2011 Aug; 59(1):55-61. PubMed ID: 21554231 [Abstract] [Full Text] [Related]
15. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma. Lu P, Sun Y, Sun Y, Yu L. Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334 [Abstract] [Full Text] [Related]
18. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma. Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G. Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617 [Abstract] [Full Text] [Related]